Wedbush Has Pessimistic View of Disc Medicine Q2 Earnings
Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Wedbush cut their Q2 2025 earnings per share (EPS) estimates for shares of Disc Medicine in a research note issued to investors on Wednesday, May 7th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of ($1.02) for the quarter, down from […]
Disc Medicine, Inc. (NASDAQ:IRON – Free Report) – Wedbush cut their Q2 2025 earnings per share (EPS) estimates for shares of Disc Medicine in a research note issued to investors on Wednesday, May 7th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of ($1.02) for the quarter, down from […]
